Results 1 to 10 of about 23,172 (159)
Case Report: Post-transplant lymphoproliferative disorder mimicking Baló’s concentric sclerosis [PDF]
Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoproliferative disease that occurs in recipients of solid organ or hematopoietic stem cell transplants, resulting from the malignant transformation of benign proliferative lymphoid or plasma ...
Xiaofeng Xiong +8 more
doaj +2 more sources
Ocular post-transplant lymphoproliferative disorder after keratoplasty [PDF]
Purpose: Epstein-Barr virus associated post-transplantation lymphoproliferative disorders (PTLD) is a common condition after solid-organ or allogeneic hematopoietic stem-cell transplants.
Linna Liu +5 more
doaj +2 more sources
Posttransplantation Lymphoproliferative Disorders [PDF]
Posttransplantation lymphoproliferative disorders include a wide spectrum of diseases ranging from hyperplastic-appearing lesions to frank non-Hodgkin lymphoma. More than 90% of these disorders are Epstein-Barr virus-associated lesions of B-cell origin that arise in the setting of pharmacologic immunosuppression after transplantation.
Andreone P +6 more
openaire +4 more sources
A case of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder is indolent clinical behaviour and uncertain malignant potential. Histologically, these lesions show a predominance of small to medium-size CD4+ pleomorphic T-cell expressing ...
Qingyu Hong +5 more
doaj +1 more source
Background Posttransplant lymphoproliferative disorder is one of the most severe complications after transplantation, caused by uncontrolled proliferation of Epstein–Barr virus-positive B-cells in the setting of chronic immunosuppression.
Alireza Keshtkar +7 more
doaj +1 more source
Ofatumumab for Post-Transplant Lymphoproliferative Disorder
Posttransplant lymphoproliferative disorder (PTLD) includes a range of abnormal lymphoid proliferation following solid organ or allogeneic hematopoietic stem cell transplantation (HSCT), often associated with Epstein—Barr virus (EBV) infection. Treatment
Madhav Seshadri +2 more
doaj +1 more source
CD30+ lymphoproliferative disorders [PDF]
CD30 antigen, originally identified as a cell surface marker of the malignant Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin’s lymphoma by the use of the Ki-1 monoclonal antibody, is a transmembrane glycoprotein member of the tumor necrosis factor (TNF) receptor superfamily.[1][1] In ...
de Leval, L., Gaulard, P.
openaire +3 more sources
Lymphoproliferative disorder after kidney transplantation [PDF]
Introduction. Post-transplant lymphoproliferative disorder (PTLD) is one of the most severe and often fatal complications observed after solid organ and bone marrow transplantations. Case outline. We present a case of a patient born in 1989 who underwent
Petrović Lada +4 more
doaj +1 more source
Mendelian susceptibility to mycobacterial disease masquerading as lymphoproliferative disorder
Mendelian susceptibility to mycobacterial diseases (MSMDs) is a rare disorder where histiocytes lack the interferon-gamma receptor and are not activated by the cytokine secreted by T-lymphocyte.
Thulasi Raman Ramalingam +1 more
doaj +1 more source
Introduction: Posttransplant lymphoproliferative disorder (PTLD) is a serious disease that usually occurs after solid organ transplant and stem cell transplant.
Jingjing Yuan MD +3 more
doaj +1 more source

